Adaptimmune Therapeutics Stock Forecast - Price Action Indicator
| ADAPDelisted Stock | USD 0.04 0 6.49% |
Adaptimmune Stock outlook is based on your current time horizon.
As of today, the value of RSI of Adaptimmune Therapeutics' share price is approaching 40. This suggests that the stock is in nutural position, most likellhy at or near its support level. The main point of RSI analysis is to track how fast people are buying or selling Adaptimmune Therapeutics, making its price go up or down. Momentum 40
Sell Extended
Oversold | Overbought |
Using Adaptimmune Therapeutics hype-based prediction, you can estimate the value of Adaptimmune Therapeutics Plc from the perspective of Adaptimmune Therapeutics response to recently generated media hype and the effects of current headlines on its competitors.
Adaptimmune Therapeutics after-hype prediction price | USD 0.0298 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as delisted stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Adaptimmune |
Adaptimmune Therapeutics Additional Predictive Modules
Most predictive techniques to examine Adaptimmune price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Adaptimmune using various technical indicators. When you analyze Adaptimmune charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Check Adaptimmune Therapeutics Volatility | Backtest Adaptimmune Therapeutics | Information Ratio |
Adaptimmune Therapeutics Trading Date Momentum
| On January 26 2026 Adaptimmune Therapeutics Plc was traded for 0.04 at the closing time. The top price for the day was 0.04 and the lowest listed price was 0.04 . There was no trading activity during the period 0.0. Lack of trading volume on January 26, 2026 did not affect price variability. The overall trading delta against the current closing price is 6.94% . |
Price Action Indicator (or PAIN) was developed by Michael B. Geraty and published in 'Futures' magazine in August 1997.
Compare Adaptimmune Therapeutics to competition
Adaptimmune Therapeutics Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Adaptimmune Therapeutics stock to make a market-neutral strategy. Peer analysis of Adaptimmune Therapeutics could also be used in its relative valuation, which is a method of valuing Adaptimmune Therapeutics by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Adaptimmune Therapeutics Market Strength Events
Market strength indicators help investors to evaluate how Adaptimmune Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Adaptimmune Therapeutics shares will generate the highest return on investment. By undertsting and applying Adaptimmune Therapeutics stock market strength indicators, traders can identify Adaptimmune Therapeutics Plc entry and exit signals to maximize returns.
Adaptimmune Therapeutics Risk Indicators
The analysis of Adaptimmune Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Adaptimmune Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting adaptimmune stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 12.64 | |||
| Semi Deviation | 15.04 | |||
| Standard Deviation | 20.28 | |||
| Variance | 411.26 | |||
| Downside Variance | 245.75 | |||
| Semi Variance | 226.23 | |||
| Expected Short fall | (16.63) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Adaptimmune Therapeutics
The number of cover stories for Adaptimmune Therapeutics depends on current market conditions and Adaptimmune Therapeutics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Adaptimmune Therapeutics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Adaptimmune Therapeutics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Adaptimmune Therapeutics Short Properties
Adaptimmune Therapeutics' future price predictability will typically decrease when Adaptimmune Therapeutics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Adaptimmune Therapeutics Plc often depends not only on the future outlook of the potential Adaptimmune Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Adaptimmune Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 252.3 M | |
| Cash And Short Term Investments | 151.6 M |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.
Other Consideration for investing in Adaptimmune Stock
If you are still planning to invest in Adaptimmune Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Adaptimmune Therapeutics' history and understand the potential risks before investing.
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |